Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.
August 1, 2011
By:
James Wright, Malcolm Horsley
Pharmaceutical Technology
Manufacturers are facing ever-increasing competition while end users are expecting better value and efficacy. The authors discuss these challenges and offer practical solutions.
|
August 1, 2011
By:
Sumeet Dagar, Sean Brynjelsen
Pharmaceutical Technology
The authors share their approach and experience working in complex, multicompany environments for in-licensed products to develop successful chemistry, manufacturing, and controls packages for managing outsourcing partnerships.
|
|
August 1, 2011
By:
Paul Smaltz, Rick Siberski
Pharmaceutical Technology
Avantor reviews its experience with the Rx-360 shared audit pilot program, which is aimed at protecting the pharmaceutical supply chain. This article is part of a special issue on Outsourcing.
|
August 1, 2011
By:
David J. Lennard, Daniel R. Matlis
Pharmaceutical Technology
The authors review current industry challenges and trends in managing global supply chains and propose best practices for improving visibility into those networks.
|
August 1, 2011
By:
Patricia Van Arnum
Pharmaceutical Technology
The article examines a cross-functional supplier integration model to facilitate project management.
|
August 1, 2011
Pharmaceutical Technology
An Industry Roundtable Moderated by Patricia Van Arnum and Rich Whitworh. Contract service and technology providers share their perspectives on the influence of quality by design in the expectations between sponsor companies and outsourcing providers.
|
|
August 1, 2011
By:
Jim Miller
Pharmaceutical Technology
Respondents to the 2011 PharmSource-Pharmaceutical Technology Outsourcing Survey paint a positive picture, but concerns linger under the surface. This article is part of a special issue on Outsourcing.
|
July 28, 2011
By:
Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
The global production of seasonal influenza vaccine will double to 1.7 billion doses by 2015, according to a World Health Organization presentation.
|
|
